Matthew Griffiths

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Anna Halliday1
Donald Stull1
Torsten Zuberbier1
Doreen McBride1
1Anna Halliday
1Donald Stull
1Torsten Zuberbier
1Doreen McBride
Learn More
BACKGROUND Chronic spontaneous urticaria (CSU) negatively impacts patient quality of life and productivity and is associated with considerable indirect costs to society. OBJECTIVE The aim of this study was to assess the cost utility of add-on omalizumab treatment compared with standard of care (SOC) in moderate or severe CSU patients with inadequate(More)
  • 1